{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:22:34Z","timestamp":1779344554563,"version":"3.51.4"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":8030,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998]]},"DOI":"10.1093\/annonc\/9.suppl_5.s5","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T23:08:34Z","timestamp":1333667314000},"page":"s5-s16","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S5","title":["Epstein\u2013Barr virus in Hodgkin\u2019s disease"],"prefix":"10.1016","volume":"9","author":[{"given":"A.L.N.","family":"Chapman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Rickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0010","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed\u2013Sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0015","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(72)92402-6","article-title":"Oral excretion of Epstein\u2013Barr virus by healthy subjects and patients with infectious mononucleosis","volume":"2","author":"Gerber","year":"1972","journal-title":"Lancet"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V85.3.744.bloodjournal853744","article-title":"Morphology, immunophenotype, and distribution of latently and\/or productively Epstein\u2013Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein\u2013Barr virus","volume":"85","author":"Anagnostopoulos","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/258236a0","article-title":"Absence of infectious Epstein\u2013Barr virus in blood in acute infectious mononucleosis","volume":"258","author":"Rickinson","year":"1975","journal-title":"Nature"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ijc.2910080312","article-title":"The establishment of lymphoblastoid cell lines from adult and from foetal human lymphoid tissue and its dependence on EBV","volume":"8","author":"Nilsson","year":"1971","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0035","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1128\/JVI.68.11.7374-7385.1994","article-title":"Epstein\u2013Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state","volume":"68","author":"Tiernay","year":"1994","journal-title":"J Virol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0042-6822(92)90307-B","article-title":"Three transcriptionally distinct forms of Epstein\u2013Barr virus latency in somatic cell hybrids. Cell phenotype dependence of virus promoter usage","volume":"187","author":"Kerr","year":"1992","journal-title":"Virology"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0045","series-title":"Fields Virology","article-title":"Epstein\u2013Barr virus","author":"Kieff","year":"1996"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.8016657","article-title":"Mediation of Epstein\u2013Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa","volume":"265","author":"Henkel","year":"1994","journal-title":"Science"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0055","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1073\/pnas.86.17.6498","article-title":"Mutually exclusive use of viral promoters in EBV latently infected lymphocytes","volume":"86","author":"Woisetschlaeger","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0060","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1073\/pnas.87.5.1725","article-title":"Promoter switching in Epstein\u2013Barr virus during the initial stages of infection of B lymphocytes","volume":"87","author":"Woisetschlaeger","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0065","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1128\/JVI.70.9.5909-5915.1996","article-title":"Epstein\u2013Barr virus EBNA3A and EBNA3B proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA","volume":"70","author":"Waltzer","year":"1996","journal-title":"J Virol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0070","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/313812a0","article-title":"Stable replication of plasmids derived from Epstein\u2013Barr virus in various mammalian cells","volume":"313","author":"Yates","year":"1985","journal-title":"Nature"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","article-title":"The Epstein\u2013Barr virus transforming protein LMP1 engages signaling proteins for the tumour-necrosis-factor receptor family","volume":"80","author":"Mosialos","year":"1995","journal-title":"Cell"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0080","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1016\/S0960-9822(98)70123-X","article-title":"Epstein-Barr virus: LMP1 masquerades as an active receptor","volume":"8","author":"Eliopoulos","year":"1998","journal-title":"Curr Biol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(97)80078-7","article-title":"Functions of CD40 on B cells, dendritic cells and other cells","volume":"9","author":"Van Kooten","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0090","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1099\/0022-1317-77-11-2807","article-title":"The latent membrane protein 2 gene of Epstein\u2013Barr virus is important for efficient B-cell immortalisation","volume":"77","author":"Brielmeier","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0095","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1073\/pnas.91.2.772","article-title":"An integral membrane protein (LMP2) blocks reactivation of Epstein\u2013Barr virus from latency following surface immunoglobulin cross-linking","volume":"91","author":"Miller","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","article-title":"Epstein\u2013Barr virus LMP2A drives B-cell development and survival in the absence of normal B-cell receptor signals","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","article-title":"EBV persistence in memory B cells in vivo","volume":"9","author":"Babcock","year":"1998","journal-title":"Immunity"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/287334a0","article-title":"Plasmacytic differentiation of circulating Epstein\u2013Barr virus infected B lymphocytes during acute infectious mononucleosis","volume":"287","author":"Robinson","year":"1980","journal-title":"Nature"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.2910170105","article-title":"EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients","volume":"17","author":"Klein","year":"1976","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0090-1229(84)90029-1","article-title":"Virologic, immunologic and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis","volume":"30","author":"Svedmyr","year":"1984","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJM197701202960302","article-title":"Quantitative evaluation of Epstein\u2013Barr virus-infected peripheral blood leucocytes in infectious mononucleosis","volume":"296","author":"Rocchi","year":"1977","journal-title":"N EngI J Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ijc.2910350107","article-title":"A re-examination of the Epstein\u2013Barr virus carrier state in healthy seropositive individuals","volume":"35","author":"Yao","year":"1985","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0135","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/eji.1830170717","article-title":"Multiple HLA class I-dependent cylotoxicities constitute the non-HLA-restricted response in infectious mononucleosis","volume":"17","author":"Strang","year":"1987","journal-title":"Eur J Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0140","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm0896-906","article-title":"Large clonal expansions of CD8+ T cells in acute infectious mononucleosis","volume":"2","author":"Callan","year":"1996","journal-title":"Nature Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0145","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.185.9.1605","article-title":"Immediate early and early lytic cycle proteins are frequent targets of the Epstein\u2013Barr virus-induced cytotoxic T-cell response","volume":"185","author":"Steven","year":"1997","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0150","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct visualisation of antigen specific CD8+ T cells during the primary immune response to Epstein\u2013Barr virus in vivo","volume":"187","author":"Callan","year":"1998","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0155","series-title":"A reevaluation of the frequency of cytotoxic T cells specific for Epstein\u2013Barr virus in long-term virus carriers","author":"Tan","year":"1998"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.176.1.157","article-title":"Identification of target antigens for the human cytotoxic T-cell response to Epstein\u2013Barr virus (EBV): Implications for the immune control of EBV-positive malignancies","volume":"176","author":"Murray","year":"1992","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.176.1.169","article-title":"Localisation of Epstein\u2013Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: Implications for vaccine development","volume":"176","author":"Khanna","year":"1992","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/375685a0","article-title":"Inhibition of antigen processing by the internal repeat region of the Epstein\u2013Barr virus nuclear antigen-1","volume":"375","author":"Levitskaya","year":"1995","journal-title":"Nature"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0175","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1074-7613(00)80397-0","article-title":"Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing","volume":"7","author":"Blake","year":"1997","journal-title":"Immunity"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0180","first-page":"977","article-title":"Molecular genetic analysis of lymphoid tumours arising after organ transplantation","volume":"135","author":"Locker","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0185","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/infdis\/152.5.876","article-title":"Epstein\u2013Barr Virus Infections and DNA Hybridisation studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection","volume":"152","author":"Ho","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0190","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.V83.9.2715.2715","article-title":"Direct correlation between the load of Epstein\u2013Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease","volume":"83","author":"Savoie","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0195","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","article-title":"Expression of Epstein\u2013Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease","volume":"321","author":"Young","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0200","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/00007890-199005000-00022","article-title":"Immunohistology of Epstein\u2013Barr virus-associated antigens in B-cell disorders from immunocompromised individuals","volume":"49","author":"Thomas","year":"1990","journal-title":"Transplantation"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"I","author":"Starzl","year":"1984","journal-title":"Lancet"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0210","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein\u2013Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein\u2013Barr virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0220","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V91.10.3654","article-title":"Semiquantitative Epstein\u2013Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem-cell transplantation","volume":"91","author":"Lucas","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0225","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein\u2013Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nature Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0230","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.4049\/jimmunol.160.12.6204","article-title":"Reconstitution of EBV-specific T-cell immunity in solid organ transplant recipients","volume":"160","author":"Haque","year":"1998","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0235","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0240","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","article-title":"Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells","volume":"79","author":"Taub","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0245","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1073\/pnas.80.15.4822","article-title":"Differential expression of the normal and of the translocated human c-myc oncogenes in B cells","volume":"80","author":"Nishikura","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0250","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood.V85.8.2176.bloodjournal8582176","article-title":"Analysis of VH genes used by neoplastic B cells in endemic Burkitt\u2019s lymphoma shows somatic hypermutation and intraclonal heterogeneity","volume":"85","author":"Chapman","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0255","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.139.1.313","article-title":"Identification of a subset of normal B cells with a Burkitt\u2019s lymphoma (BL)-like phenotype","volume":"139","author":"Gregory","year":"1987","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0260","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<229::AID-PATH86>3.0.CO;2-L","article-title":"Germinal centre kinetics","volume":"185","author":"Hollowood","year":"1998","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0265","series-title":"Pathogenesis of Leukaemias and Lymphomas: Environmental Influences","first-page":"283","article-title":"Burkitt type lymphoma: EBV association and cytogenetic markers in cases from various geographical locations","author":"Lenoir","year":"1984"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0270","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","article-title":"Differences in B cell growth phenotype reflect novel patterns of Epstein\u2013Barr virus latent gene expression in Burkitt\u2019s lymphoma cells","volume":"6","author":"Rowe","year":"1987","journal-title":"EMBO J"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0275","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","article-title":"Expression of Epstein\u2013Barr virus nuclear antigen-l induces B cell neoplasia in transgenic mice","volume":"15","author":"Wilson","year":"1996","journal-title":"EMBO J"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0280","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1084\/jem.167.6.1811","article-title":"Down regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein\u2013Barr virus-positive Burkitt\u2019s lymphoma underlies tumour cell escape from virus-specific T-cell surveillance","volume":"167","author":"Gregory","year":"1998","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0285","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/intimm\/6.4.639","article-title":"Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line","volume":"6","author":"Khanna","year":"1994","journal-title":"Internat Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0290","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ijc.2910470412","article-title":"Aberrant expression of HLA class I antigens in Burkitt\u2019s Lymphoma cells","volume":"47","author":"Andersson","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0295","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1128\/MCB.15.11.6150","article-title":"Transcriptional activation of the Epstein\u2013Barr latency C promoter after 5-azacytidine treatment \u2013 evidence that demethylation at a single CPG site is crucial","volume":"15","author":"Robertson","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0300","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.4049\/jimmunol.159.12.5782","article-title":"Cutting edge: Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt\u2019s lymphoma cells","volume":"159","author":"Khanna","year":"1997","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0305","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/intimm\/9.10.1537","article-title":"Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: Evidence for HLA-DM-independent processing","volume":"9","author":"Khanna","year":"1997","journal-title":"Int Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0310","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0950-3536(96)80018-7","article-title":"The epidemiology of Hodgkin\u2019s disease","volume":"9","author":"Glaser","year":"1996","journal-title":"Bailliere\u2019s Clin Haematol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ijc.2910220104","article-title":"Infectious mononucleosis and Hodgkin\u2019s disease","volume":"22","author":"Munoz","year":"1978","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0320","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/1097-0142(197102)27:2<416::AID-CNCR2820270227>3.0.CO;2-W","article-title":"Elevated antibody titers to Epstein\u2013Barr virus in Hodgkin\u2019s disease","volume":"27","author":"Levine","year":"1971","journal-title":"Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0325","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198903163201103","article-title":"Hodgkin\u2019s disease and Epstein\u2013Barr virus. Altered antibody patterns before diagnosis","volume":"320","author":"Mueller","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0330","first-page":"86","article-title":"Epstein\u2013Barr viral DNA in tissues of Hodgkin\u2019s disease","volume":"129","author":"Weiss","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0335","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection of Epstein\u2013Barr viral genomes in Reed\u2013Sternberg cells of Hodgkin\u2019s disease","volume":"320","author":"Weiss","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0340","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.88.11.4766","article-title":"Epstein\u2013Barr virus latent membrane protein expression in Hodgkin and Reed\u2013Sternberg cells","volume":"88","author":"Herbst","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0345","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-J","article-title":"Expression of Epstein\u2013Barr virus latent gene products in tumour cells of Hodgkin\u2019s disease","volume":"337","author":"Pallesen","year":"1991","journal-title":"Lancet"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0350","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ijc.2910460509","article-title":"Detection of EBV gene expression in Reed\u2013Sternberg cells of Hodgkin\u2019s disease","volume":"46","author":"Wu","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0355","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V77.8.1781.1781","article-title":"Detection of Epstein\u2013Barr virus messenger RNA in Reed\u2013Sternberg cells of Hodgkin\u2019s disease by in situ hybridisation with biotinylated probes on specially processed modified acetone methyl benzoate xylene (Mod AMeX) sections","volume":"77","author":"Brousset","year":"1991","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0360","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/(SICI)1097-0215(19960315)65:6<781::AID-IJC13>3.0.CO;2-7","article-title":"Neoplastic cells of Hodgkin\u2019s disease show differences in EBV expression between Kenya and Italy","volume":"65","author":"Leoncini","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0365","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0046-8177(95)90064-0","article-title":"Detection of Epstein\u2013Barr virus in Hodgkin\u2019s disease occurring in an oriental population","volume":"26","author":"Chan","year":"1995","journal-title":"Human Pathol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0370","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00000478-199405000-00014","article-title":"Nodular lymphocyte predominance Hodgkin\u2019s disease. A clinicopathological entity","volume":"18","author":"Mason","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0375","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/10428199209051008","article-title":"Recent results on the biology of Hodgkin and Reed\u2013Sternberg cells. I. Biopsy material","volume":"8","author":"Drexler","year":"1992","journal-title":"Leuk Lymph"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0380","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","article-title":"Hodgkin disease: Hodgkin and Reed\u2013Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development","volume":"91","author":"Kuppers","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0385","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.immunol.16.1.471","article-title":"The origin of Hodgkin and Reed\u2013Sternberg cells in Hodgkin\u2019s disease","volume":"16","author":"Kuppers","year":"1998","journal-title":"Ann Rev Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0390","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood.V74.2.810.810","article-title":"Demonstration of monoclonal EBV genomes in Hodgkin\u2019s disease and Ki-1-positive anaplastic large-cell lymphoma by combined Southern blot and in situ hybridisation","volume":"74","author":"Anagnostopoulos","year":"1989","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0395","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","article-title":"Epstein\u2013Barr virus and Hodgkin\u2019s disease: Transcriptional analysis of virus latency in the malignant cells","volume":"177","author":"Deacon","year":"1993","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0400","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/infdis\/173.3.529","article-title":"Epstein\u2013Barr virus DNA recombination and loss in sporadic Burkitt\u2019s lymphoma","volume":"173","author":"Razzouk","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0405","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(89)90829-5","article-title":"Detection of a second widespread strain of Epstein\u2013Barr virus","author":"Sixbey","year":"1989","journal-title":"Lancet"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0410","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1128\/JVI.64.9.4084-4092.1990","article-title":"Epstein\u2013Barr virus type 1 and type 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes","volume":"64","author":"Sample","year":"1990","journal-title":"J Virol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0415","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/bjc.1991.281","article-title":"Viral involvement in Hodgkin\u2019s disease: Detection of clonal type A Epstein\u2013Barr virus genomes in tumour samples","volume":"64","author":"Gledhill","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0420","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1182\/blood.V81.2.468.468","article-title":"Subtypes of Epstein\u2013Barr virus (EBV) in Hodgkin\u2019s disease. Association between B-type EBV and immunocompromise","volume":"81","author":"Boyle","year":"1993","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0425","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/infdis\/162.3.642","article-title":"Coinfection with A- and B-type Epstein\u2013Barr virus in human immunodeficiency virus-positive subjects","volume":"162","author":"Sculley","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0430","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1099\/0022-1317-72-10-2399","article-title":"Isolation and sequencing of the Epstein\u2013Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma","volume":"72","author":"Hu","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0435","first-page":"2131","article-title":"Cloning and characterisation of the latent membrane protein (LMP) of a specific Epstein\u2013Barr virus variant derived from nasopharyngeal carcinoma in the Taiwanese population","volume":"7","author":"Chen","year":"1992","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0440","first-page":"1575","article-title":"Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1","volume":"8","author":"Hu","year":"1993","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0445","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0959-8049(05)80024-3","article-title":"Epstein\u2013Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B-cell-derived homologue","volume":"30A","author":"Trivedi","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0450","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood.V82.10.2937.2937","article-title":"Deletions within the LMP1 oncogene of Epstein\u2013Barr virus are clustered in Hodgkin\u2019s disease and identical to those observed in nasopharyngeal carcinoma","volume":"82","author":"Knecht","year":"1993","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0455","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V89.5.1723.1723_1723_1731","article-title":"Epstein\u2013Barr virus strains with latent membrane protein-1 deletions: Prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin\u2019s disease","volume":"89","author":"Dolcetti","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0460","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1182\/blood.V88.9.3491.bloodjournal8893491","article-title":"Analysis of Epstein\u2013Barr virus gene polymorphisms in normal donors and in virus-associated tumours from different geographic locations","volume":"88","author":"Khanim","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0465","first-page":"177","article-title":"Variation in the sequence of Epstein\u2013Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt\u2019s lymphomas","volume":"13","author":"Bhatia","year":"1996","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"10.1093\/annonc\/9.suppl_5.S5_bb0470","first-page":"6","article-title":"EBNA-1 subtypes in Hodgkin\u2019s disease and other Epstein\u2013Barr virus-associated lymphomas","volume":"29","author":"MacKenzie","year":"1998","journal-title":"Leuk Lymph"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0475","first-page":"673","article-title":"The impact of Hodgkin\u2019s disease on the immune system","volume":"17","author":"Slivnik","year":"1990","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0480","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood.V88.1.236.236","article-title":"T cells from patients with Hodgkin\u2019s disease have a defective T-cell receptor z chain expression that is reversible by T-cell stimulation with CD3 and CD28","volume":"88","author":"Renner","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0485","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ijc.2910610605","article-title":"Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumour-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease","volume":"61","author":"Matsuda","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0490","first-page":"1327","article-title":"Alterations in T-cell receptor and signal transduction molecules in melanoma patients","volume":"1","author":"Zea","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0495","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V91.8.2925.2925_2925_2934","article-title":"Epstein\u2013Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin\u2019s disease","volume":"91","author":"Roskrow","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0500","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V89.6.1978","article-title":"Isolation of Epstein\u2013Barr Virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed\u2013Sternberg cells: Implications for immune-mediated therapy of EBV-positive Hodgkin\u2019s disease","volume":"89","author":"Sing","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0505","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.immunol.14.1.369","article-title":"Antigen processing and presentation by the class I major histocompatibility complex","volume":"14","author":"York","year":"1996","journal-title":"Ann Rev Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0510","first-page":"37","article-title":"Absence of HLA class I expression by Reed\u2013Sternberg cells","volume":"145","author":"Poppema","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0515","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood.V87.9.3844.bloodjournal8793844","article-title":"Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein\u2013Barr virus-positive and -negative Hodgkin\u2019s disease","volume":"87","author":"Oudejaans","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0520","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V92.3.1020","article-title":"Antigen presenting phenotype of Hodgkin\/Reed\u2013Sternberg cells: Analysis of the HLA class I processing pathway and the effects of interleukin-10 on Epstein\u2013Barr virus-specific cytotoxic T-cell recognition","volume":"92","author":"Lee","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0525","first-page":"3675","article-title":"Identification and characterisation of an Epstein\u2013Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin\u2019s disease","volume":"54","author":"Dolcetti","year":"1995","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0530","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood.V86.4.1493.bloodjournal8641493","article-title":"Local suppression of Epstein\u2013Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin\u2019s disease","volume":"86","author":"Frisan","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0535","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V87.7.2918.bloodjournal8772918","article-title":"Frequent expression of interleukin 10 by Epstein\u2013Barr virus-harboring tumour cells of Hodgkin\u2019s disease","volume":"87","author":"Herbst","year":"1996","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1093\/annonc\/9.suppl_5.S5_bb0540","first-page":"3938","article-title":"The absence of effective T-cell activation in Hodgkin\u2019s disease may be the result of TGF-B production by Reed\u2013Sternberg cells","volume":"90","author":"Potters","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0545","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"Interleukin-10 and viral interleukin-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression","volume":"174","author":"de Waal-Malefyt","year":"1991","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0550","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V92.11.4256","article-title":"Interleukin-10 abrogates the inhibition of Epstein\u2013Barr virus induced B-cell transformation by memory T-cell responses","author":"Bejarano","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0555","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood.V85.12.3378.bloodjournal85123378","article-title":"Tumor-necrosis-factor ligand superfamily \u2013 involvement in the pathology of malignant lymphomas","volume":"85","author":"Gruss","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0560","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10428199509064920","article-title":"The antigen-presenting-cell function of Reed\u2013Sternberg cells","volume":"18","author":"Delabie","year":"1995","journal-title":"Leuk Lymph"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0565","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1128\/JVI.67.12.7428-7435.1993","article-title":"HLA A2.1-restricted cytotoxic T cells recognising a range of Epstein\u2013Barr virus isolates through a defined epitope in latent membrane protein LMP2","volume":"67","author":"Lee","year":"1993","journal-title":"J Virol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0570","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.4049\/jimmunol.158.7.3325","article-title":"Conserved cytotoxic T lymphocyte (CTL) epitopes within Epstein\u2013Barr virus (EBV) latent membrane protein 2, a potential target for CTL-based therapy","volume":"158","author":"Lee","year":"1997","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0575","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<451::AID-IMMU451>3.0.CO;2-U","article-title":"Identification of cytotoxic T cell epitopes within Epstein\u2013Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): Evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes","volume":"28","author":"Khanna","year":"1998","journal-title":"Eur J Immunol"},{"issue":"Suppl","key":"10.1093\/annonc\/9.suppl_5.S5_bb0580","first-page":"33A","article-title":"Analysis of MHC class I and TAP expression and LMP2 epitope sequence in EBV-positive Hodgkin\u2019s disease","volume":"184","author":"Constandinou","year":"1998","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0585","article-title":"Accessing Epstein\u2013Barr virus-specific T-cell memory with peptide-loaded dendritic cells","author":"Redchenko","year":"1998","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0590","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.183.1.283","article-title":"Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumour immunity","volume":"183","author":"Celluzi","year":"1996","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/9.suppl_5.S5_bb0595","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nature Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419625202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419625202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/suppl_5\/S5\/6680868\/9-suppl_5-S5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T21:52:38Z","timestamp":1713822758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419625202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"references-count":118,"alternative-id":["S0923753419625202"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/9.suppl_5.s5","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1998]]}}}